December 20, 2021
Advance Online
Advance Online
New Treatment for PsA
The U.S. FDA approves upadacitinib for the treatment of adults with active psoriatic arthritis.
The U.S. FDA approves upadacitinib for the treatment of adults with active psoriatic arthritis.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.